ICM
QTRX icon

Invenomic Capital Management’s Quanterix QTRX Stock Holding History

Invenomic Capital Management’s Portfolio QTRX Stock Details QTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,932,386
Closed -$6.8M – 151
2026
Q1 		$6.8M Buy
1,932,386
+427,178
+28% +$2.49M 0.31% 84
2025
Q4 		$9.57M Buy
1,505,208
+112,203
+8% +$697K 0.45% 73
2025
Q3 		$7.56M Buy
1,393,005
+248,101
+22% +$1.32M 0.37% 83
2025
Q2 		$7.61M Buy
1,144,904
+242,861
+27% +$1.35M 0.43% 74
2025
Q1 		$5.87M Buy
+902,043
New +$7.53M 0.3% 103

Other funds holding QTRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $159M AUM 139.66% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lionhunter Capital Management New York $222M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Invenomic Capital Management's QTRX Position: Q2 2026 in Review

Invenomic Capital Management sold out of Quanterix (QTRX) in Q2 2026, closing a stake of 1,932,386 shares — an estimated $6.8M sold.

Invenomic Capital Management first reported a position in QTRX in Q1 2025 and held it in 5 quarters. The position peaked at $9.57M in Q4 2025. 133 funds tracked by Wall St. Rank hold QTRX as of Q2 2026.

  • Invenomic Capital Management reported no remaining Quanterix position as of Q2 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 1,932,386 Quanterix shares in Q2 2026, an estimated $6.8M.
  • Invenomic Capital Management first reported a position in Quanterix in Q1 2025 and held it in 5 quarters.
  • Invenomic Capital Management's Quanterix position peaked at $9.57M in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Quanterix as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.